All In MedTech

Device Trial Radar · NCT01520324

Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy

Intraepithelial Neoplasia Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Patients With Long Standing Ulcerative Colitis Undergoing Colonoscopy.

Last checked: Nov 19, 2026Latest source record: Feb 8, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

53

Actual

Start

Jan 2012

Primary completion

Jul 2012

Study completion Jul 2012

Sponsor

Lead sponsor
Cosmo Technologies LtdNot on our public-company list
Sponsor type
Industry
First posted
Jan 27, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluation of the intraepithelial neoplasia detection rate in patients with long standing ulcerative colitis undergoing mucosal staining with oral methylene blue MMX tablets prior to colonoscopy.

Conditions

  • Ulcerative Colitis

Interventions

  • oral delivery mucosal stainDevice

    200mg methylene blue MMX tablet taken prior to colonoscopy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Detected Intraepithelial NeoplasiaTime frame: During colonscopy (usually <15 min) and subsequent histological analysis
  2. Intraepithelial Neoplasia (IN) Detection Rate (True Positive Findings)Time frame: During colonscopy (usually <15 min) and subsequent histological analysis
  3. Intraepithelial Neoplasia (IN) Detection Rate (False Positive Findings)Time frame: During colonscopy (usually <15 min) and subsequent histological analysis

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Centre for Research & Care of Intestinal Diseases

    Rozzano, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.